PT981525E - Novos intermediarios e processo para a sua preparacao - Google Patents

Novos intermediarios e processo para a sua preparacao

Info

Publication number
PT981525E
PT981525E PT98921668T PT98921668T PT981525E PT 981525 E PT981525 E PT 981525E PT 98921668 T PT98921668 T PT 98921668T PT 98921668 T PT98921668 T PT 98921668T PT 981525 E PT981525 E PT 981525E
Authority
PT
Portugal
Prior art keywords
preparation
new intermediaries
thienyl
general formula
intermediaries
Prior art date
Application number
PT98921668T
Other languages
English (en)
Inventor
Alain Heymes
Bertrand Castro
Maria Bakonyi
Marianna Csatarine Nagy
Leventene Molnar
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of PT981525E publication Critical patent/PT981525E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
PT98921668T 1997-05-13 1998-05-11 Novos intermediarios e processo para a sua preparacao PT981525E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9700886A HU225504B1 (en) 1997-05-13 1997-05-13 Novel halophenyl-(2-(2-thienyl)-ethylamino)-acetonitriles and process for producing them

Publications (1)

Publication Number Publication Date
PT981525E true PT981525E (pt) 2004-05-31

Family

ID=89995121

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98921668T PT981525E (pt) 1997-05-13 1998-05-11 Novos intermediarios e processo para a sua preparacao

Country Status (14)

Country Link
US (1) US6215005B1 (pt)
EP (1) EP0981525B1 (pt)
JP (1) JP4279903B2 (pt)
AT (1) ATE258551T1 (pt)
AU (1) AU7444698A (pt)
BR (1) BR9809113B1 (pt)
CA (1) CA2288637C (pt)
DE (1) DE69821347T2 (pt)
DK (1) DK0981525T3 (pt)
ES (1) ES2213900T3 (pt)
HU (1) HU225504B1 (pt)
NO (1) NO325305B1 (pt)
PT (1) PT981525E (pt)
WO (1) WO1998051682A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU226421B1 (en) * 1998-11-09 2008-12-29 Sanofi Aventis Process for racemizing optically active 2-(2-chlorophenyl)-2-(2-(2-thienyl)-ethylamino)-acetamides
US6495691B1 (en) 2001-07-06 2002-12-17 Brantford Chemicals Inc. Process for the preparation of tetrahydrothieno[3,2-c]pyridine derivatives
US6767913B2 (en) 2001-12-18 2004-07-27 Teva Pharmaceutical Industries Ltd. Crystal forms iii, iv, v, and novel amorphous form of clopidogrel hydrogensulfate, processes for their preparation, processes for the preparation of form i, compositions containing the new forms and methods of administering the new forms
US7074928B2 (en) 2002-01-11 2006-07-11 Teva Pharmaceutical Industries, Ltd. Polymorphs of clopidogrel hydrogensulfate
HUP0200438A3 (en) * 2002-02-06 2003-10-28 Egis Gyogyszergyar Nyilvanosan Novel clopidogrel hydrochloride polymorphs, process for the preparation thereof, their use and pharmaceutical compositions containing them
IL166593A0 (en) 2002-08-02 2006-01-15 Racemization and enantiomer separation of clopidogrel
US6800759B2 (en) * 2002-08-02 2004-10-05 Teva Pharmaceutical Industries Ltd. Racemization and enantiomer separation of clopidogrel
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate
US20040250673A1 (en) * 2003-06-10 2004-12-16 Salerno Paul Michael Ergonomic pedal board
GB0321256D0 (en) 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1680430B1 (en) 2003-11-03 2010-01-20 Cadila Healthcare Ltd. Processes for preparing form i of (s)-(+)- clopidogrel bisulfate
US20060154957A1 (en) * 2004-09-21 2006-07-13 Nina Finkelstein Crystalline clopidogrel hydrobromide and processes for preparation thereof
TW200640932A (en) * 2005-02-24 2006-12-01 Teva Pharma Clopidogrel base suitable for pharmaceutical formulation and preparation thereof
EP1902058A2 (en) 2005-07-12 2008-03-26 RPG Life Sciences Limited A process for preparation of methyl-(+)-(s)-alpha-(2-chlorophenyl)-6,7-dihydrothieno(3,2-c)pyridine-5(4h)-acetic acid methyl ester or salts thereof having higher chiral purity and products thereof
KR20090013794A (ko) * 2006-04-27 2009-02-05 인드-스위프트 래버러토리즈 리미티드 클로피도그렐 히드로겐 설페이트의 다형태의 제조방법
US20090247569A1 (en) * 2006-08-03 2009-10-01 Claude Singer Process for Preparing Clopidogrel Bisulphate
EP1980563A1 (en) 2007-04-09 2008-10-15 BATTULA, Srinivasa Reddy Procedure for the preparation of methyl (+)-(S)-Alpha-(O-chlorophenyl)-6,7-dihydrothieno-[3,2-C]pyridine-5(4H) acetate
EP2346879A1 (en) * 2008-10-24 2011-07-27 Sandoz AG A process for the preparation of s-clopidogrel

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2508455A1 (fr) 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de derives des (thienyl-2)- et (thienyl-3)-2 ethylamines
FR2530247B1 (fr) 1982-07-13 1986-05-16 Sanofi Sa Nouveaux derives de la thieno (3, 2-c) pyridine, leur procede de preparation et leur application therapeutique
FR2608607B1 (fr) 1986-12-23 1989-04-28 Sanofi Sa Procede de preparation de thienylethylamines et dithienylethylamines ainsi obtenues
FR2623810B2 (fr) 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2614619B1 (fr) 1987-04-29 1989-09-15 Sanofi Sa Procede de preparation de n-((chloro-2)-benzyl) (thienyl-2)-2 ethylamine
FR2652575B1 (fr) * 1989-09-29 1992-01-24 Sanofi Sa Procede de preparation d'acides alpha-bromo phenylacetiques.
FR2664596B1 (fr) * 1990-07-10 1994-06-10 Sanofi Sa Procede de preparation d'un derive n-phenylacetique de tetrahydrothieno [3,2-c] pyridine et son intermediaire de synthese.
CA2265886A1 (en) * 1996-09-12 1998-03-19 Rhone-Poulenc Rorer Pharmaceuticals Inc. Stereospecific preparation of chiral 1-aryl- and 1-heteroaryl-2-substituted ethyl-2-amines

Also Published As

Publication number Publication date
HUP9700886A2 (hu) 1999-09-28
NO995531D0 (no) 1999-11-12
BR9809113A (pt) 2000-08-01
AU7444698A (en) 1998-12-08
US6215005B1 (en) 2001-04-10
NO995531L (no) 1999-12-13
NO325305B1 (no) 2008-03-25
DE69821347D1 (de) 2004-03-04
EP0981525B1 (en) 2004-01-28
ES2213900T3 (es) 2004-09-01
HU225504B1 (en) 2007-01-29
DE69821347T2 (de) 2004-12-02
WO1998051682A1 (en) 1998-11-19
JP2001525817A (ja) 2001-12-11
BR9809113B1 (pt) 2010-03-09
EP0981525A1 (en) 2000-03-01
CA2288637C (en) 2005-11-15
DK0981525T3 (da) 2004-05-10
CA2288637A1 (en) 1998-11-19
ATE258551T1 (de) 2004-02-15
JP4279903B2 (ja) 2009-06-17
HU9700886D0 (en) 1997-07-28
HUP9700886A3 (en) 2000-06-28

Similar Documents

Publication Publication Date Title
PT981524E (pt) Novos intermediarios e processo para sua preparacao
PT981525E (pt) Novos intermediarios e processo para a sua preparacao
BR9909844A (pt) Processo para sintetizar um composto, e, composto.
CY1109276T1 (el) Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων
NO984344L (no) Ny asymmetriske syntese av R-<alfa>-propylpiperonyalamin og dets analoger
BR0316400A (pt) agentes branqueadores fluorescentes anfotéricos
BR9808923A (pt) Composto, e, processo para fazer o mesmo
BR9814774B1 (pt) processo para a preparação de (-)cis-3-hidróxi-1-metil-4-(2,4,6-trimetoxifenil)-piperidi na e intermediários para sua preparação.
PT1206452E (pt) Processo de preparacao de compostos benzoper-hidroisoindole
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
BR9807785A (pt) Processo para a preparação do composto, e, composto
BR0012622A (pt) Derivados de 3-amino-2-benzil-1-fenil-propano
DK0975601T3 (da) Fremgangsmåde til fremstilling af butylthio-isoquinolin og mellemprodukter derfor
BR9710386B1 (pt) processo de preparação de um composto e processo de transformação do composto.
BR0016781A (pt) Bases de 1-naftol e 2-naftol - mannich substituìdas
BR9907340A (pt) Ciclo-heptenos substituìdos, e processo para a produção de um composto
DK1086114T3 (da) Morfin-6-glucuronidsyntese
BR9909756A (pt) Processo para a preparação de um composto
BR9807913A (pt) 7-acilamino-3-(metilhidrazono)metil cefalosporinas substituìdas antibacterianas e intermediários
DK0931055T3 (da) Selektiv alkylering af en alkohol-substitueret phenolforbindelse
BR9911977A (pt) Acilaminofenil-uracilas substituìdas
ES2192324T3 (es) Procedimiento para preparar una feniltiobutil-isoquinolina y sus intermedios.
BR9609156A (pt) Processo para a síntese de benzo(b)tiofenos
PT818464E (pt) Metilsulfomicina i processo para a sua producao e utilizacao
ES2188222T3 (es) Sintesis enantioselectiva.